Watch Presentation:
Federal and State Policy Updates: Market Access Implications and 2026 Planning

Federal and State Policy Updates: Market Access Implications and 2026 Planning

In this edition of the Navigating Market Access with Magnolia webinar series, industry experts discuss the latest federal and state policy developments shaping drug pricing, market access, and 2026 strategic planning.

  • Federal updates on Most Favored Nation (MFN), Direct-to-Patient (DTP) initiatives, and pharmaceutical tariffs
  • State-level policy trends impacting PBMs, 340B programs, and utilization management
  • How state legislation in 2025 is reshaping pharmacy contracting, reimbursement, and transparency
  • Practical implications of new federal and state activity for manufacturers and payers
  • Forward-looking strategies for navigating market access in a changing policy environment

Panelists include: